Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Duke University 1967
• 

  Previous Appointments & Affiliations

  • Professor of Surgery with Tenure, Surgery, Surgical Sciences, Surgery 1977 - 2002
  • James B. Duke Distinguished Professor of Medicine, Surgery, Surgical Sciences, Surgery 1984 - 2002
  • Professor of Virology in the Department of Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 1994 - 2002
  • Professor of Virology in the Department of Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2001 - 2002
  • Vice Chair, Department of Surgery, Surgery, Clinical Science Departments 1994 - 1999
  • Associate Professor of Surgery, Surgery, Surgical Sciences, Surgery 1972 - 1977
  • Assistant Professor of Virology in the Department of Surgery, Surgery, Surgical Sciences, Surgery 1971 - 1972
• Research
• 

  Selected Grants

  • Utilizing Nucleic Acid Binding Polymers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer awarded by National Institutes of Health 2018 - 2021
  • Host Virus Interactions During Acute Infection awarded by National Institutes of Health 1996 - 1999
  • Viral Control And Immune Reconstitution In Hiv Infection awarded by National Institutes of Health 1996 - 1999
  • Viral Control & Immune Reconstitution In Hiv Infection awarded by National Institutes of Health 1995 - 1999
  • Duke University Center For Aids Research awarded by National Institutes of Health 1996 - 1999
  • Duke University Center For Aids Research awarded by National Institutes of Health 1994 - 1999
  • Center For Aids Research awarded by National Institutes of Health 1989 - 1999
  • Duke University Center For Aids Research awarded by National Institutes of Health 1989 - 1999
  • Molecularly-Defined Taa As Human Anti-Tumor Ctl Targets awarded by National Institutes of Health 1993 - 1997
  • Molecularly-Defined Taa As Human Anti-Tumor Ctl Targets awarded by National Institutes of Health 1992 - 1997
  • Molecularly-Defined Taa As Human Anti-Tumor Ctl Targets awarded by National Institutes of Health 1992 - 1997
  • Aveg Central Immunology Lab awarded by National Institutes of Health 1995 - 1996
  • Aveg Central Immunology Laboratory awarded by National Institutes of Health 1994 - 1996
  • Central Immunology Laboratory For Aids Vaccine Clinical Tr awarded by National Institutes of Health 1991 - 1996
  • The Thymus In Immune Reconstitution For Hiv Infection awarded by National Institutes of Health 1994 - 1995
  • Pre-Clinical Trials On Prevention & Intervention In Aids awarded by National Institutes of Health 1993 - 1995
  • Pre-Clinical Studies Of Prevention And Intervention In Aid awarded by National Institutes of Health 1991 - 1995
  • Pre-Clinical Studies On Prevention & Intervention In Aids awarded by National Institutes of Health 1986 - 1995
  • Immunologic Assays awarded by National Institutes of Health 1993 - 1994
  • Central Immunology Lab For Aids Vaccine awarded by National Institutes of Health 1994
  • Duke University Center For Aids Research awarded by National Institutes of Health 1993 - 1994
  • Duke University Medical Center Center For Aids Research awarded by National Institutes of Health 1991 - 1994
  • Duke University Medical Center For Aids Research awarded by National Institutes of Health 1989 - 1994
  • Supplement To Aveg Central Immunology Laboratory awarded by National Institutes of Health 1992 - 1993
  • Establishment Of An Aids Treatment Evaluation Unit (Actu) awarded by National Institutes of Health 1991
  • Nucleoside And Oligonucleotide Analogs For Aids Therapy awarded by National Institutes of Health 1990 - 1991
  • Pre-Clinical Studies Of Prevention/Intervention Aids awarded by National Institutes of Health 1990 - 1991
  • The Establishment Of An Aids Treatment Evaluation Unit awarded by National Institutes of Health 1990 - 1991
  • Pre-Clinical Studies Of Prevention & Intervention In Aids awarded by National Institutes of Health 1989 - 1991
  • The Establishment Of Aids Treatment Evaluation Unit awarded by National Institutes of Health 1988 - 1991
  • Clinical Studies On Prevention And Intervention In Aids awarded by National Institutes of Health 1987 - 1991
  • The Establishment Of Aids Treatment Evaluation Units awarded by National Institutes of Health 1987 - 1991
  • Nucleoside And Oligonucleotide Analogs For Aids Therapy awarded by National Institutes of Health 1986 - 1987
  • Control Of Neoplasia By Passive Serum Therapy awarded by National Institutes of Health 1984 - 1985
• 

  External Relationships

  • Istari Oncology Inc.
  • Upstream Therapeutics
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Gromeier, Matthias, Michael C. Brown, Gao Zhang, Xiang Lin, Yeqing Chen, Zhi Wei, Nike Beaubier, et al. “Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.” Nat Commun 12, no. 1 (January 13, 2021): 352. https://doi.org/10.1038/s41467-020-20469-6.
       Full Text  Open Access Copy  Link to Item
    • Desjardins, Annick, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, et al. “Recurrent Glioblastoma Treated with Recombinant Poliovirus.” N Engl J Med 379, no. 2 (July 12, 2018): 150–61. https://doi.org/10.1056/NEJMoa1716435.
       Full Text  Link to Item
    • Lu, Rong-Jian, John A. Tucker, Jason Pickens, You-An Ma, Tatiana Zinevitch, Olga Kirichenko, Vitalii Konoplev, et al. “Heterobiaryl human immunodeficiency virus entry inhibitors.” J Med Chem 52, no. 14 (July 23, 2009): 4481–87. https://doi.org/10.1021/jm900330x.
       Full Text  Link to Item
    • Lu, Rong-Jian, John A. Tucker, Tatiana Zinevitch, Olga Kirichenko, Vitalii Konoplev, Svetlana Kuznetsova, Sergey Sviridov, et al. “Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.” J Med Chem 50, no. 26 (December 27, 2007): 6535–44. https://doi.org/10.1021/jm070650e.
       Full Text  Link to Item
    • Matthews, Tom, Miklos Salgo, Michael Greenberg, Jain Chung, Ralph DeMasi, and Dani Bolognesi. “Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.” Nat Rev Drug Discov 3, no. 3 (March 2004): 215–25. https://doi.org/10.1038/nrd1331.
       Full Text  Link to Item
    • Bolognesi, Dani P. “Basic science in a department of surgery.” Ann Surg 238, no. 6 Suppl (December 2003): S33. https://doi.org/10.1097/01.sla.0000097512.84296.79.
       Full Text  Link to Item
    • LaBranche, C. C., G. Galasso, J. P. Moore, D. P. Bolognesi, M. S. Hirsch, and S. M. Hammer. “HIV fusion and its inhibition.” Antiviral Res 50, no. 2 (May 2001): 95–115. https://doi.org/10.1016/s0166-3542(01)00130-9.
       Full Text  Link to Item
    • Chen, C. H., M. L. Greenberg, D. P. Bolognesi, and T. J. Matthews. “Monoclonal antibodies that bind to the core of fusion-active glycoprotein 41.” Aids Res Hum Retroviruses 16, no. 18 (December 10, 2000): 2037–41. https://doi.org/10.1089/088922200750054765.
       Full Text  Link to Item
    • McElrath, M. J., L. Corey, D. Montefiori, M. Wolff, D. Schwartz, M. Keefer, R. Belshe, et al. “A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.” Aids Res Hum Retroviruses 16, no. 9 (June 10, 2000): 907–19. https://doi.org/10.1089/08892220050042846.
       Full Text  Link to Item
    • Markert, M. L., C. B. Hicks, J. A. Bartlett, J. L. Harmon, L. P. Hale, M. L. Greenberg, G. Ferrari, et al. “Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.” Aids Res Hum Retroviruses 16, no. 5 (March 20, 2000): 403–13. https://doi.org/10.1089/088922200309061.
       Full Text  Link to Item
    • Gorse, G. J., G. B. Patel, M. Mandava, P. W. Berman, and R. B. Belshe. “MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.” Aids Res Hum Retroviruses 15, no. 10 (July 1, 1999): 921–30. https://doi.org/10.1089/088922299310638.
       Full Text  Link to Item
    • Salmon-Céron, D., J. L. Excler, L. Finkielsztejn, B. Autran, J. C. Gluckman, D. Sicard, T. J. Matthews, et al. “Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection. AGIS Group and L'Agence Nationale de Recherches sur Le Sida.” Aids Res Hum Retroviruses 15, no. 7 (May 1, 1999): 633–45. https://doi.org/10.1089/088922299310935.
       Full Text  Link to Item
    • Kilby, J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, et al. “Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.” Nat Med 4, no. 11 (November 1998): 1302–7. https://doi.org/10.1038/3293.
       Full Text  Link to Item
    • Tyler, D. S., S. D. Stanley, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.” J Surg Res 79, no. 2 (October 1998): 115–20. https://doi.org/10.1006/jsre.1998.5415.
       Full Text  Link to Item
    • Langlois, A. J., R. C. Desrosiers, M. G. Lewis, V. N. KewalRamani, D. R. Littman, J. Y. Zhou, K. Manson, M. S. Wyand, D. P. Bolognesi, and D. C. Montefiori. “Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus.” J Virol 72, no. 8 (August 1998): 6950–55. https://doi.org/10.1128/JVI.72.8.6950-6955.1998.
       Full Text  Link to Item
    • Montefiori, D. C., K. A. Reimann, M. S. Wyand, K. Manson, M. G. Lewis, R. G. Collman, J. G. Sodroski, D. P. Bolognesi, and N. L. Letvin. “Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.” J Virol 72, no. 4 (April 1998): 3427–31. https://doi.org/10.1128/JVI.72.4.3427-3431.1998.
       Full Text  Link to Item
    • Montefiori, D. C., R. G. Collman, T. R. Fouts, J. Y. Zhou, M. Bilska, J. A. Hoxie, J. P. Moore, and D. P. Bolognesi. “Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.” J Virol 72, no. 3 (March 1998): 1886–93. https://doi.org/10.1128/JVI.72.3.1886-1893.1998.
       Full Text  Link to Item
    • Bolognesi, D. P., and T. J. Matthews. “HIV vaccines. Viral envelope fails to deliver?” Nature 391, no. 6668 (February 12, 1998): 638–39. https://doi.org/10.1038/35504.
       Full Text  Link to Item
    • Bolognesi, D. P. “New perspectives on AIDS vaccine development: Editorial.” Aids Research and Human Retroviruses 14, no. SUPPL. 3 (January 1, 1998).
    • Pilgrim, A. K., G. Pantaleo, O. J. Cohen, L. M. Fink, J. Y. Zhou, J. T. Zhou, D. P. Bolognesi, A. S. Fauci, and D. C. Montefiori. “Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.” J Infect Dis 176, no. 4 (October 1997): 924–32. https://doi.org/10.1086/516508.
       Full Text  Link to Item
    • Bolognesi, D. P. “HIV. A clever hijacker of the immune system.” Curr Opin Immunol 9, no. 4 (August 1997): 549–50. https://doi.org/10.1016/s0952-7915(97)80109-4.
       Full Text  Link to Item
    • Ferrari, G., W. Humphrey, M. J. McElrath, J. L. Excler, A. M. Duliege, M. L. Clements, L. C. Corey, D. P. Bolognesi, and K. J. Weinhold. “Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.” Proc Natl Acad Sci U S A 94, no. 4 (February 18, 1997): 1396–1401. https://doi.org/10.1073/pnas.94.4.1396.
       Full Text  Link to Item
    • Page, C., N. Voelkel, and M. Ichinose. “Editorial.” Pulm Pharmacol Ther 10, no. 1 (February 1997): 1. https://doi.org/10.1006/pupt.1997.0079.
       Full Text  Link to Item
    • Greenberg, M. L., S. F. Lacey, C. H. Chen, D. P. Bolognesi, and K. J. Weinhold. “Noncytolytic CD8 T cell-mediated suppression of HIV replication.” Springer Semin Immunopathol 18, no. 3 (1997): 355–69. https://doi.org/10.1007/BF00813503.
       Full Text  Link to Item
    • Graham, B. S., M. C. Keefer, M. J. McElrath, G. J. Gorse, D. H. Schwartz, K. Weinhold, T. J. Matthews, J. R. Esterlitz, F. Sinangil, and P. E. Fast. “Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.” Ann Intern Med 125, no. 4 (August 15, 1996): 270–79. https://doi.org/10.7326/0003-4819-125-4-199608150-00003.
       Full Text  Link to Item
    • Gorse, G. J., G. B. Patel, F. K. Newman, R. B. Belshe, P. W. Berman, T. J. Gregory, and T. J. Matthews. “Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.” Clin Diagn Lab Immunol 3, no. 4 (July 1996): 378–86. https://doi.org/10.1128/cdli.3.4.378-386.1996.
       Full Text  Link to Item
    • Bolognesi, D. P. “Overview of HIV vaccine development.” Antibiot Chemother (1971) 48 (1996): 63–67. https://doi.org/10.1159/000425159.
       Full Text  Link to Item
    • Matthews, T. J., D. Davison, L. Rimsky-Clark, and D. P. Bolognesi. “Measurements of humoral immune responses directed to HIV-1: Comparison of infection and vaccine induced antibody reactivities.” Medecine Biologie Environnement 23, no. 2 (December 1, 1995): 193–201.
    • Bolognesi, D. P., and M. D. Cooper. “Immunodeficiency.” Curr Opin Immunol 7, no. 4 (August 1995): 433–35. https://doi.org/10.1016/0952-7915(95)80084-0.
       Full Text  Link to Item
    • Ferrari, G., K. King, K. Rathbun, C. A. Place, M. V. Packard, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).” Clin Exp Immunol 101, no. 2 (August 1995): 239–48. https://doi.org/10.1111/j.1365-2249.1995.tb08345.x.
       Full Text  Link to Item
    • Chen, C. H., T. J. Matthews, C. B. McDanal, D. P. Bolognesi, and M. L. Greenberg. “A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion.” J Virol 69, no. 6 (June 1995): 3771–77. https://doi.org/10.1128/JVI.69.6.3771-3777.1995.
       Full Text  Link to Item
    • Ahearne, P. M., R. A. Morgan, M. W. Sebastian, D. P. Bolognesi, and K. J. Weinhold. “Multiple CTL specificities against autologous HIV-1-infected BLCLs.” Cell Immunol 161, no. 1 (March 1995): 34–41. https://doi.org/10.1006/cimm.1995.1006.
       Full Text  Link to Item
    • Keefer, M. C., B. S. Graham, R. B. Belshe, D. Schwartz, L. Corey, D. P. Bolognesi, D. M. Stablein, D. C. Montefiori, M. J. McElrath, and M. L. Clements. “Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.” Aids Res Hum Retroviruses 10, no. 12 (December 1994): 1713–23. https://doi.org/10.1089/aid.1994.10.1713.
       Full Text  Link to Item
    • Hoth, D. F., D. P. Bolognesi, L. Corey, and S. H. Vermund. “NIH conference. HIV vaccine development: a progress report.” Ann Intern Med 121, no. 8 (October 15, 1994): 603–11. https://doi.org/10.7326/0003-4819-121-8-199410150-00008.
       Full Text  Link to Item
    • Graham, B. S., G. J. Gorse, D. H. Schwartz, M. C. Keefer, M. J. McElrath, T. J. Matthews, P. F. Wright, R. B. Belshe, M. L. Clements, and R. Dolin. “Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.” J Infect Dis 170, no. 4 (October 1994): 782–86. https://doi.org/10.1093/infdis/170.4.782.
       Full Text  Link to Item
    • Belshe, R. B., D. P. Bolognesi, M. L. Clements, L. Corey, R. Dolin, J. Mestecky, M. Mulligan, D. Stablein, and P. Wright. “HIV infection in vaccinated volunteers.” Jama 272, no. 6 (August 10, 1994): 431. https://doi.org/10.1001/jama.272.6.431b.
       Full Text  Link to Item
    • Belshe, R. B., D. P. Bolognesi, M. L. Clements, L. Corey, R. Dolin, J. Mestecky, M. Mulligan, D. Stablein, and P. Wright. “HIV Infection in Vaccinated Volunteers.” Jama: The Journal of the American Medical Association 272, no. 6 (August 10, 1994): 431. https://doi.org/10.1001/jama.1994.03520060029015.
       Full Text
    • Belshe, R. B., B. S. Graham, M. C. Keefer, G. J. Gorse, P. Wright, R. Dolin, T. Matthews, K. Weinhold, D. P. Bolognesi, and R. Sposto. “Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.” Jama 272, no. 6 (August 10, 1994): 475–80. https://doi.org/10.1001/jama.272.6.475.
       Full Text  Link to Item
    • Cooper, M. D., and D. P. Bolognesi. “Immunodeficiency.” Curr Opin Immunol 6, no. 4 (August 1994): 597–99. https://doi.org/10.1016/0952-7915(94)90147-3.
       Full Text  Link to Item
    • Matthews, T. J., C. Wild, C. H. Chen, D. P. Bolognesi, and M. L. Greenberg. “Structural rearrangements in the transmembrane glycoprotein after receptor binding.” Immunol Rev 140 (August 1994): 93–104. https://doi.org/10.1111/j.1600-065x.1994.tb00866.x.
       Full Text  Link to Item
    • Petteway, S. R., D. P. Bolognesi, and T. J. Matthews. “The viral transmembrane protein: A target for the discovery of novel antivirals.” International Antiviral News 2, no. 7 (July 22, 1994): 98–99.
    • Ferrari, G., C. A. Place, P. M. Ahearne, S. M. Nigida, L. O. Arthur, D. P. Bolognesi, and K. J. Weinhold. “Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees.” J Acquir Immune Defic Syndr (1988) 7, no. 4 (April 1994): 325–31.
       Link to Item
    • Javaherian, K., A. J. Langlois, D. C. Montefiori, K. A. Kent, K. A. Ryan, P. D. Wyman, J. Stott, D. P. Bolognesi, M. Murphey-Corb, and G. J. Larosa. “Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.” J Virol 68, no. 4 (April 1994): 2624–31. https://doi.org/10.1128/JVI.68.4.2624-2631.1994.
       Full Text  Link to Item
    • Belshe, R. B., M. L. Clements, R. Dolin, B. S. Graham, J. McElrath, G. J. Gorse, D. Schwartz, M. C. Keefer, P. Wright, and L. Corey. “Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.” J Infect Dis 168, no. 6 (December 1993): 1387–95. https://doi.org/10.1093/infdis/168.6.1387.
       Full Text  Link to Item
    • Chen, C. H., K. J. Weinhold, J. A. Bartlett, D. P. Bolognesi, and M. L. Greenberg. “CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism.” Aids Res Hum Retroviruses 9, no. 11 (November 1993): 1079–86. https://doi.org/10.1089/aid.1993.9.1079.
       Full Text  Link to Item
    • Haynes, B. F., J. V. Torres, A. J. Langlois, D. P. Bolognesi, M. B. Gardner, T. J. Palker, R. M. Scearce, D. M. Jones, M. A. Moody, and C. McDanal. “Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.” J Immunol 151, no. 3 (August 1, 1993): 1646–53.
       Link to Item
    • Bolognesi, D. P. “The immune response to HIV: implications for vaccine development.” Semin Immunol 5, no. 3 (June 1993): 203–14. https://doi.org/10.1006/smim.1993.1024.
       Full Text  Link to Item
    • Temin, H. M., and D. P. Bolognesi. “AIDS. Where has HIV been hiding?” Nature 362, no. 6418 (March 25, 1993): 292–93. https://doi.org/10.1038/362292a0.
       Full Text  Link to Item
    • Graham, B. S., T. J. Matthews, R. B. Belshe, M. L. Clements, R. Dolin, P. F. Wright, G. J. Gorse, D. H. Schwartz, M. C. Keefer, and D. P. Bolognesi. “Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.” J Infect Dis 167, no. 3 (March 1993): 533–37. https://doi.org/10.1093/infdis/167.3.533.
       Full Text  Link to Item
    • Haynes, B. F., L. O. Arthur, P. Frost, T. J. Matthews, A. J. Langlois, T. J. Palker, M. K. Hart, R. M. Scearce, D. M. Jones, and C. McDanal. “Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.” J Exp Med 177, no. 3 (March 1, 1993): 717–27. https://doi.org/10.1084/jem.177.3.717.
       Full Text  Link to Item
    • Bolognesi, D. P. “Human immunodeficiency virus vaccines.” Adv Virus Res 42 (1993): 103–48. https://doi.org/10.1016/s0065-3527(08)60084-6.
       Full Text  Link to Item
    • Haynes, B. F., Y. Yasutomi, J. V. Torres, M. B. Gardner, A. J. Langlios, D. P. Bolognesi, T. J. Matthews, R. M. Scearce, D. M. Jones, and M. A. Moody. “Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.” Trans Assoc Am Physicians 106 (1993): 33–41.
       Link to Item
    • Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. “A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.” Proc Natl Acad Sci U S A 89, no. 21 (November 1, 1992): 10537–41. https://doi.org/10.1073/pnas.89.21.10537.
       Full Text  Link to Item
    • Gorse, G. J., S. E. Frey, F. K. Newman, and R. B. Belshe. “Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network.” J Clin Microbiol 30, no. 10 (October 1992): 2606–12. https://doi.org/10.1128/jcm.30.10.2606-2612.1992.
       Full Text  Link to Item
    • Langlois, A. J., K. J. Weinhold, T. J. Matthews, M. L. Greenberg, and D. P. Bolognesi. “Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus.” Aids Res Hum Retroviruses 8, no. 9 (September 1992): 1641–52. https://doi.org/10.1089/aid.1992.8.1641.
       Full Text  Link to Item
    • Van Veldhoven, P. P., T. J. Matthews, D. P. Bolognesi, and R. M. Bell. “Changes in bioactive lipids, alkylacylglycerol and ceramide, occur in HIV-infected cells.” Biochem Biophys Res Commun 187, no. 1 (August 31, 1992): 209–16. https://doi.org/10.1016/s0006-291x(05)81480-9.
       Full Text  Link to Item
    • Lambert, D. M., S. R. Petteway, C. E. McDanal, T. K. Hart, J. J. Leary, G. B. Dreyer, T. D. Meek, P. J. Bugelski, D. P. Bolognesi, and B. W. Metcalf. “Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.” Antimicrob Agents Chemother 36, no. 5 (May 1992): 982–88. https://doi.org/10.1128/AAC.36.5.982.
       Full Text  Link to Item
    • Javaherian, K., A. J. Langlois, S. Schmidt, M. Kaufmann, N. Cates, J. P. Langedijk, R. H. Meloen, R. C. Desrosiers, D. P. Burns, and D. P. Bolognesi. “The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.” Proc Natl Acad Sci U S A 89, no. 4 (February 15, 1992): 1418–22. https://doi.org/10.1073/pnas.89.4.1418.
       Full Text  Link to Item
    • Langlois, A. J., K. J. Weinhold, T. J. Matthews, M. L. Greenberg, and D. P. Bolognesi. “The ability of certain SIV vaccines to provoke reactions against normal cells.” Science 255, no. 5042 (January 17, 1992): 292–93. https://doi.org/10.1126/science.1549775.
       Full Text  Link to Item
    • Karzon, D. T., D. P. Bolognesi, and W. C. Koff. “Development of a vaccine for the prevention of AIDS, a critical appraisal.” Vaccine 10, no. 14 (1992): 1039–52. https://doi.org/10.1016/0264-410x(92)90114-y.
       Full Text  Link to Item
    • Bolognesi, D. P. “Perspectives on the development of anti-HIV vaccines.” Curr Opin Biotechnol 2, no. 6 (December 1991): 893–96. https://doi.org/10.1016/s0958-1669(05)80127-2.
       Full Text  Link to Item
    • Langlois, A. J., K. J. Weinhold, T. J. Matthews, and D. P. Bolognesi. “In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.” Aids Res Hum Retroviruses 7, no. 8 (August 1991): 713–20. https://doi.org/10.1089/aid.1991.7.713.
       Full Text  Link to Item
    • Shadduck, P. P., J. B. Weinberg, A. F. Haney, J. A. Bartlett, A. J. Langlois, D. P. Bolognesi, and T. J. Matthews. “Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.” J Virol 65, no. 8 (August 1991): 4309–16. https://doi.org/10.1128/JVI.65.8.4309-4316.1991.
       Full Text  Link to Item
    • Stine, K. C., D. S. Tyler, S. D. Stanley, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals.” Cell Immunol 136, no. 1 (August 1991): 165–72. https://doi.org/10.1016/0008-8749(91)90391-n.
       Full Text  Link to Item
    • Bolognesi, D. P. “AIDS vaccines: progress and unmet challenges.” Ann Intern Med 114, no. 2 (January 15, 1991): 161–62. https://doi.org/10.7326/0003-4819-114-2-161.
       Full Text  Link to Item
    • Bolognesi, D. P. “HIV vaccine development: perspective.” Biotechnol Ther 2, no. 1–2 (1991): 205–11.
       Link to Item
    • Gardner, M. B., J. R. Carlson, M. Jennings, A. Rosenthal, A. Langlois, B. Haynes, D. Bolognesi, and T. J. Palker. “SIV vaccine protection of rhesus monkeys.” Biotechnol Ther 2, no. 1–2 (1991): 9–19.
       Link to Item
    • Matthews, T. J., A. J. Langlois, S. Butto, D. Bolognesi, and K. Javaherian. “HIV-1 neutralizing antibody and approaches to the envelope diversity problem.” Adv Exp Med Biol 303 (1991): 23–26. https://doi.org/10.1007/978-1-4684-6000-1_3.
       Full Text  Link to Item
    • Javaherian, K., A. J. Langlois, G. J. LaRosa, A. T. Profy, D. P. Bolognesi, W. C. Herlihy, S. D. Putney, and T. J. Matthews. “Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.” Science 250, no. 4987 (December 14, 1990): 1590–93. https://doi.org/10.1126/science.1703322.
       Full Text  Link to Item
    • Bolognesi, D. P., and G. C. Schild. “Vaccines and immunology: Overview.” Aids 4, no. SUPPL. 1 (December 1, 1990).
    • Tyler, D. S., S. D. Stanley, S. Zolla-Pazner, M. K. Gorny, P. P. Shadduck, A. J. Langlois, T. J. Matthews, D. P. Bolognesi, T. J. Palker, and K. J. Weinhold. “Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.” J Immunol 145, no. 10 (November 15, 1990): 3276–82.
       Link to Item
    • Hart, M. K., T. J. Palker, T. J. Matthews, A. J. Langlois, N. W. Lerche, M. E. Martin, R. M. Scearce, C. McDanal, D. P. Bolognesi, and B. F. Haynes. “Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.” J Immunol 145, no. 8 (October 15, 1990): 2677–85.
       Link to Item
    • LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, and P. Shadduck. “Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.” Science 249, no. 4971 (August 24, 1990): 932–35. https://doi.org/10.1126/science.2392685.
       Full Text  Link to Item
    • Bolognesi, D. “Vaccine development for HIV infection.” J Am Acad Dermatol 22, no. 6 Pt 2 (June 1990): 1295–99. https://doi.org/10.1016/0190-9622(90)70176-i.
       Full Text  Link to Item
    • Tyler, D. S., S. D. Stanley, C. A. Nastala, A. A. Austin, J. A. Bartlett, K. C. Stine, H. K. Lyerly, D. P. Bolognesi, and K. J. Weinhold. “Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.” J Immunol 144, no. 9 (May 1, 1990): 3375–84.
       Link to Item
    • Bolognesi, D. P. “HIV immunization. Fresh pathways to follow.” Nature 344, no. 6269 (April 26, 1990): 818–19. https://doi.org/10.1038/344818a0.
       Full Text  Link to Item
    • Bolognesi, D. P. “Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies.” Mol Biol Med 7, no. 1 (February 1990): 1–15.
       Link to Item
    • Bolognesi, D. P. “Approaches to HIV vaccine design.” Trends Biotechnol 8, no. 2 (February 1990): 40–45. https://doi.org/10.1016/0167-7799(90)90131-g.
       Full Text  Link to Item
    • Bolognesi, D. P. “Progress in vaccine development against SIV and HIV.” J Acquir Immune Defic Syndr (1988) 3, no. 4 (1990): 390–94.
       Link to Item
    • Bolognesi, D. P. “Introduction.” Aids Research and Human Retroviruses 6, no. 1 (January 1, 1990): 1. https://doi.org/10.1089/aid.1990.6.1.
       Full Text
    • Bolognesi, D. P., and G. C. Schild. “AIDS 1990. Vaccines and immunology: overview.” Aids 4 Suppl 1 (1990): S127–28.
       Link to Item
    • Bolognesi, D. “Editorial.” Aids Research and Human Retroviruses 6, no. 7 (January 1, 1990). https://doi.org/10.1089/aid.1990.6.vii.
       Full Text
    • Putney, S. D., J. Rusche, K. Javaherian, T. Matthews, and D. Bolognesi. “Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.” Biotechnology 14 (1990): 81–110. https://doi.org/10.1016/b978-0-409-90116-0.50013-3.
       Full Text  Link to Item
    • Bolognesi, D. P. “Progress in vaccines against AIDS.” Science 246, no. 4935 (December 8, 1989): 1233–34. https://doi.org/10.1126/science.2555922.
       Full Text  Link to Item
    • Stine, K. C., D. Bolognesi, and K. J. Weinhold. “Cytokine augmentation of human immunodeficiency virus type 1 (HIV-1) gp120-specific cellular cytotoxicity.” J Biol Response Mod 8, no. 5 (October 1989): 501–10.
       Link to Item
    • Javaherian, K., A. J. Langlois, C. McDanal, K. L. Ross, L. I. Eckler, C. L. Jellis, A. T. Profy, J. R. Rusche, D. P. Bolognesi, and S. D. Putney. “Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.” Proc Natl Acad Sci U S A 86, no. 17 (September 1989): 6768–72. https://doi.org/10.1073/pnas.86.17.6768.
       Full Text  Link to Item
    • Bolognesi, D. P. “AIDS. Do antibodies enhance the infection of cells by HIV?” Nature 340, no. 6233 (August 10, 1989): 431–32. https://doi.org/10.1038/340431a0.
       Full Text  Link to Item
    • Bolognesi, D. P. “Prospects for prevention of and early intervention against HIV.” Jama 261, no. 20 (May 26, 1989): 3007–13.
       Link to Item
    • Palker, T. J., T. J. Matthews, A. Langlois, M. E. Tanner, M. E. Martin, R. M. Scearce, J. E. Kim, J. A. Berzofsky, D. P. Bolognesi, and B. F. Haynes. “Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.” J Immunol 142, no. 10 (May 15, 1989): 3612–19.
       Link to Item
    • Weinhold, K. J., H. K. Lyerly, S. D. Stanley, A. A. Austin, T. J. Matthews, and D. P. Bolognesi. “HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.” J Immunol 142, no. 9 (May 1, 1989): 3091–97.
       Link to Item
    • Tyler, D. S., C. L. Nastala, S. D. Stanley, T. J. Matthews, H. K. Lyerly, D. P. Bolognesi, and K. J. Weinhold. “GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.” J Immunol 142, no. 4 (February 15, 1989): 1177–82.
       Link to Item
    • Bolognesi, D. P. “HIV antibodies and vaccine design.” Aids 3 Suppl 1 (1989): S111–18. https://doi.org/10.1097/00002030-198901001-00016.
       Full Text  Link to Item
    • Bolognesi, D. P. “Immunobiology of the HIV envelope.” Ann N Y Acad Sci 567 (1989): 69–81. https://doi.org/10.1111/j.1749-6632.1989.tb16460.x.
       Full Text  Link to Item
    • Skinner, M. A., A. J. Langlois, C. B. McDanal, J. S. McDougal, D. P. Bolognesi, and T. J. Matthews. “Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.” J Virol 62, no. 11 (November 1988): 4195–4200. https://doi.org/10.1128/JVI.62.11.4195-4200.1988.
       Full Text  Link to Item
    • Matthews, T. J., and D. P. Bolognesi. “AIDS vaccines.” Sci Am 259, no. 4 (October 1988): 120–27. https://doi.org/10.1038/scientificamerican1088-120.
       Full Text  Link to Item
    • Buckheit, R. W., D. P. Bolognesi, and K. J. Weinhold. “The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.” Virology 166, no. 2 (October 1988): 533–41. https://doi.org/10.1016/0042-6822(88)90524-7.
       Full Text  Link to Item
    • Bolognesi, D. P. “Natural immunity to HIV and its possible relationship to vaccine strategies.” Microbiol Sci 5, no. 8 (August 1988): 236–41.
       Link to Item
    • Chaffee, S., J. M. Leeds, T. J. Matthews, K. J. Weinhold, M. Skinner, D. P. Bolognesi, and M. S. Hershfield. “Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines.” J Exp Med 168, no. 2 (August 1, 1988): 605–21. https://doi.org/10.1084/jem.168.2.605.
       Full Text  Link to Item
    • Richardson, N. E., N. R. Brown, R. E. Hussey, A. Vaid, T. J. Matthews, D. P. Bolognesi, and E. L. Reinherz. “Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.” Proc Natl Acad Sci U S A 85, no. 16 (August 1988): 6102–6. https://doi.org/10.1073/pnas.85.16.6102.
       Full Text  Link to Item
    • Ahearne, P. M., T. J. Matthews, H. K. Lyerly, G. C. White, D. P. Bolognesi, and K. J. Weinhold. “Cellular immune response to viral peptides in patients exposed to HIV.” Aids Res Hum Retroviruses 4, no. 4 (August 1988): 259–67. https://doi.org/10.1089/aid.1988.4.259.
       Full Text  Link to Item
    • Rusche, J. R., K. Javaherian, C. McDanal, J. Petro, D. L. Lynn, R. Grimaila, A. Langlois, R. C. Gallo, L. O. Arthur, and P. J. Fischinger. “Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.” Proc Natl Acad Sci U S A 85, no. 9 (May 1988): 3198–3202. https://doi.org/10.1073/pnas.85.9.3198.
       Full Text  Link to Item
    • Smiley, M. L., G. C. White, P. Becherer, G. Macik, T. J. Matthews, K. J. Weinhold, C. McMillan, and D. Bolognesi. “Transmission of human immunodeficiency virus to sexual partners of hemophiliacs.” Am J Hematol 28, no. 1 (May 1988): 27–32. https://doi.org/10.1002/ajh.2830280106.
       Full Text  Link to Item
    • Weinhold, K. J., H. K. Lyerly, T. J. Matthews, D. S. Tyler, P. M. Ahearne, K. C. Stine, A. J. Langlois, D. T. Durack, and D. P. Bolognesi. “Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.” Lancet 1, no. 8591 (April 23, 1988): 902–5. https://doi.org/10.1016/s0140-6736(88)91713-8.
       Full Text  Link to Item
    • Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. “Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.” Proc Natl Acad Sci U S A 85, no. 6 (March 1988): 1932–36. https://doi.org/10.1073/pnas.85.6.1932.
       Full Text  Link to Item
    • Langlois, A. J., T. J. Matthews, K. J. Weinhold, S. Chaffee, M. Hershfield, and D. P. Bolognesi. “Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay.” Aids Res Hum Retroviruses 4, no. 1 (February 1988): 63–69. https://doi.org/10.1089/aid.1988.4.63.
       Full Text  Link to Item
    • Buckheit, R. W., J. Kurtzberg, D. P. Bolognesi, and K. J. Weinhold. “The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice.” Virology 162, no. 2 (February 1988): 354–61. https://doi.org/10.1016/0042-6822(88)90475-8.
       Full Text  Link to Item
    • Buckheit, R. W., S. N. Liberman, D. P. Bolognesi, and K. J. Weinhold. “The effects of leukemosuppressive immunotherapy on thymic infectious cell centers in AKR mice.” Thymus 12, no. 3 (1988): 143–56.
       Link to Item
    • Skinner, M. A., T. J. Matthews, T. K. Greenwall, D. P. Bolognesi, and M. Hebdon. “AZT inhibits HIV-1 replication in monocytes.” J Acquir Immune Defic Syndr (1988) 1, no. 2 (1988): 162–63.
       Link to Item
    • Thiel, K., E. V. Genovesi, J. D. Iglehart, D. P. Bolognesi, and K. J. Weinhold. “Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.” Adv Exp Med Biol 239 (1988): 169–83. https://doi.org/10.1007/978-1-4757-5421-6_17.
       Full Text  Link to Item
    • Lyerly, H. K., M. A. Skinner, D. S. Tyler, C. L. Nastala, T. J. Matthews, D. P. Bolognesi, and K. J. Weinhold. “Anti-HIV-1 immune cytolysis is independent of viral envelope glycosylation.” Surgical Forum 39 (January 1, 1988): 420–22.
    • Tyler, D. S., C. L. Nastala, H. K. Lyerly, T. J. Matthews, D. P. Bolognesi, and K. J. Weinhold. “Direct antibody-dependent cellular cytotoxicity: Evidence of circulating antibody-armed cytotoxic CD16+ NK/K cells in patients infected with HIV-1.” Surgical Forum 39 (January 1, 1988): 418–20.
    • Arthur, L. O., S. W. Pyle, P. L. Nara, J. W. Bess, M. A. Gonda, J. C. Kelliher, R. V. Gilden, W. G. Robey, D. P. Bolognesi, and R. C. Gallo. “Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.” Proc Natl Acad Sci U S A 84, no. 23 (December 1987): 8583–87. https://doi.org/10.1073/pnas.84.23.8583.
       Full Text  Link to Item
    • Rusche, J. R., D. L. Lynn, M. Robert-Guroff, A. J. Langlois, H. K. Lyerly, H. Carson, K. Krohn, A. Ranki, R. C. Gallo, and D. P. Bolognesi. “Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.” Proc Natl Acad Sci U S A 84, no. 19 (October 1987): 6924–28. https://doi.org/10.1073/pnas.84.19.6924.
       Full Text  Link to Item
    • Matthews, T. J., K. J. Weinhold, H. K. Lyerly, A. J. Langlois, H. Wigzell, and D. P. Bolognesi. “Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.” Proc Natl Acad Sci U S A 84, no. 15 (August 1987): 5424–28. https://doi.org/10.1073/pnas.84.15.5424.
       Full Text  Link to Item
    • Thiel, H. J., H. Schwarz, P. Fischinger, D. Bolognesi, and W. Schäfer. “Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome.” Proc Natl Acad Sci U S A 84, no. 16 (August 1987): 5893–97. https://doi.org/10.1073/pnas.84.16.5893.
       Full Text  Link to Item
    • Lyerly, H. K., T. J. Matthews, A. J. Langlois, D. P. Bolognesi, and K. J. Weinhold. “Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.” Proc Natl Acad Sci U S A 84, no. 13 (July 1987): 4601–5. https://doi.org/10.1073/pnas.84.13.4601.
       Full Text  Link to Item
    • Wahren, B., L. Morfeldt-Månsson, G. Biberfeld, L. Moberg, A. Sönnerborg, P. Ljungman, A. Werner, R. Kurth, R. Gallo, and D. Bolognesi. “Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.” J Virol 61, no. 6 (June 1987): 2017–23. https://doi.org/10.1128/JVI.61.6.2017-2023.1987.
       Full Text  Link to Item
    • Palker, T. J., T. J. Matthews, M. E. Clark, G. J. Cianciolo, R. R. Randall, A. J. Langlois, G. C. White, B. Safai, R. Snyderman, and D. P. Bolognesi. “A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.” Proc Natl Acad Sci U S A 84, no. 8 (April 1987): 2479–83. https://doi.org/10.1073/pnas.84.8.2479.
       Full Text  Link to Item
    • Buckheit, R. W., D. P. Bolognesi, and K. J. Weinhold. “The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice.” Virology 157, no. 2 (April 1987): 387–96. https://doi.org/10.1016/0042-6822(87)90281-9.
       Full Text  Link to Item
    • Lyerly, H. K., T. J. Matthews, P. M. Aherne, A. J. Langlois, D. P. Bolognesi, and K. J. Weinhold. “Augmentation of anti-HIV ADCC with interleukin-2.” Surgical Forum 38 (January 1, 1987): 425–28.
    • Matthews, T. J., A. J. Langlois, W. G. Robey, N. T. Chang, R. C. Gallo, P. J. Fischinger, and D. P. Bolognesi. “Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.” Haematol Blood Transfus 31 (1987): 414–22. https://doi.org/10.1007/978-3-642-72624-8_89.
       Full Text  Link to Item
    • Matthews, T. J., H. K. Lyerly, K. J. Weinhold, A. J. Langlois, J. Rusche, S. D. Putney, R. C. Gallo, and D. P. Bolognesi. “Prospects for development of a vaccine against HTLV-III-related disorders.” Aids Res Hum Retroviruses 3 Suppl 1 (1987): 197–206. https://doi.org/10.1089/aid.1987.3.197.
       Full Text  Link to Item
    • Putney, S. D., T. J. Matthews, W. G. Robey, D. L. Lynn, M. Robert-Guroff, W. T. Mueller, A. J. Langlois, J. Ghrayeb, S. R. Petteway, and K. J. Weinhold. “HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.” Science 234, no. 4782 (December 12, 1986): 1392–95. https://doi.org/10.1126/science.2431482.
       Full Text  Link to Item
    • Fischinger, P. J., R. C. Gallo, and D. P. Bolognesi. “Toward a vaccine against AIDS: rationale and current progress.” Mt Sinai J Med 53, no. 8 (December 1986): 639–47.
       Link to Item
    • Matthews, T. J., A. J. Langlois, W. G. Robey, N. T. Chang, R. C. Gallo, P. J. Fischinger, and D. P. Bolognesi. “Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.” Proc Natl Acad Sci U S A 83, no. 24 (December 1986): 9709–13. https://doi.org/10.1073/pnas.83.24.9709.
       Full Text  Link to Item
    • Furman, P. A., J. A. Fyfe, M. H. St Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. N. Lehrman, D. P. Bolognesi, S. Broder, and H. Mitsuya. “Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.” Proc Natl Acad Sci U S A 83, no. 21 (November 1986): 8333–37. https://doi.org/10.1073/pnas.83.21.8333.
       Full Text  Link to Item
    • Robey, W. G., L. O. Arthur, T. J. Matthews, A. Langlois, T. D. Copeland, N. W. Lerche, S. Oroszlan, D. P. Bolognesi, R. V. Gilden, and P. J. Fischinger. “Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.” Proc Natl Acad Sci U S A 83, no. 18 (September 1986): 7023–27. https://doi.org/10.1073/pnas.83.18.7023.
       Full Text  Link to Item
    • Nahmias, A. J., J. Weiss, X. Yao, F. Lee, R. Kodsi, M. Schanfield, T. Matthews, D. Bolognesi, D. Durack, and A. Motulsky. “Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.” Lancet 1, no. 8492 (May 31, 1986): 1279–80. https://doi.org/10.1016/s0140-6736(86)91422-4.
       Full Text  Link to Item
    • Schwarz, H., H. J. Thiel, K. Weinhold, P. Fischinger, D. Bolognesi, and W. Schäfer. “Properties of mouse leukemia viruses: XX. Variation of AKR Substrains in response to antibody therapy.” Virology 150, no. 1 (April 15, 1986): 247–51. https://doi.org/10.1016/0042-6822(86)90283-7.
       Full Text  Link to Item
    • White, G. C., T. J. Matthews, K. J. Weinhold, B. F. Haynes, H. L. Cromartie, C. W. McMillan, and D. P. Bolognesi. “HTLV-III seroconversion associated with heat-treated factor VIII concentrate.” Lancet 1, no. 8481 (March 15, 1986): 611–12. https://doi.org/10.1016/s0140-6736(86)92828-x.
       Full Text  Link to Item
    • Yarchoan, R., R. W. Klecker, K. J. Weinhold, P. D. Markham, H. K. Lyerly, D. T. Durack, E. Gelmann, S. N. Lehrman, R. M. Blum, and D. W. Barry. “Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.” Lancet 1, no. 8481 (March 15, 1986): 575–80. https://doi.org/10.1016/s0140-6736(86)92808-4.
       Full Text  Link to Item
    • Bolognesi, D. P., and P. J. Fischinger. “Prospects for treatment of human retrovirus-associated diseases.” Cancer Research 45, no. 9 SUPPL. (December 1, 1985).
    • Fischinger, P. J., W. G. Robey, H. Koprowski, R. C. Gallo, and D. P. Bolognesi. “Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).” Cancer Research 45, no. 9 SUPPL. (December 1, 1985).
    • Langlois, A. J., T. J. Matthews, K. J. Weinhold, and D. P. Bolognesi. “Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.” J Natl Cancer Inst 75, no. 4 (October 1985): 709–15.
       Link to Item
    • Matthews, T. J., K. J. Weinhold, A. J. Langlois, and D. P. Bolognesi. “Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.” J Natl Cancer Inst 75, no. 4 (October 1985): 703–8.
       Link to Item
    • Mitsuya, H., K. J. Weinhold, P. A. Furman, M. H. St Clair, S. N. Lehrman, R. C. Gallo, D. Bolognesi, D. W. Barry, and S. Broder. “3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.” Proc Natl Acad Sci U S A 82, no. 20 (October 1985): 7096–7100. https://doi.org/10.1073/pnas.82.20.7096.
       Full Text  Link to Item
    • Weinhold, K. J., D. P. Bolognesi, and T. J. Matthews. “Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.” J Natl Cancer Inst 75, no. 4 (October 1985): 717–24.
       Link to Item
    • Bolognesi, D. P., and P. J. Fischinger. “Prospects for treatment of human retrovirus-associated diseases.” Cancer Res 45, no. 9 Suppl (September 1985): 4700s-4705s.
       Link to Item
    • Fischinger, P. J., W. G. Robey, H. Koprowski, R. C. Gallo, and D. P. Bolognesi. “Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).” Cancer Res 45, no. 9 Suppl (September 1985): 4694s-4699s.
       Link to Item
    • Langweiler, M., K. J. Weinhold, T. J. Matthews, and D. P. Bolognesi. “Murine in vitro antigenic modification of tumor cells: effect on susceptibility to natural cell-mediated cytotoxicity.” J Natl Cancer Inst 74, no. 3 (March 1985): 699–704.
       Link to Item
    • Palker, T. J., D. P. Bolognesi, and B. F. Haynes. “Human T-cell leukemia/lymphoma virus: studies of host-virus interaction.” Curr Top Microbiol Immunol 115 (1985): 247–66. https://doi.org/10.1007/978-3-642-70113-9_16.
       Full Text  Link to Item
    • Lobach, D. F., D. P. Bolognesi, and R. E. Kaufman. “Retroviruses and human cancer: evaluation of T-lymphocyte transformation by human T-cell leukemia-lymphoma virus.” Cancer Invest 3, no. 2 (1985): 145–60. https://doi.org/10.3109/07357908509017497.
       Full Text  Link to Item
    • Weinhold, K. J., G. Hüper, T. J. Matthews, P. J. Fischinger, J. N. Ihle, H. Schwarz, H. J. Thiel, W. Schäfer, and D. P. Bolognesi. “Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus.” Virology 135, no. 1 (May 1984): 105–17. https://doi.org/10.1016/0042-6822(84)90121-1.
       Full Text  Link to Item
    • Palker, T. J., R. M. Scearce, S. E. Miller, M. Popovic, D. P. Bolognesi, R. C. Gallo, and B. F. Haynes. “Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV.” J Exp Med 159, no. 4 (April 1, 1984): 1117–31. https://doi.org/10.1084/jem.159.4.1117.
       Full Text  Link to Item
    • Johnson, W. J., D. P. Bolognesi, and D. O. Adams. “Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis.” Cell Immunol 83, no. 1 (January 1984): 170–80. https://doi.org/10.1016/0008-8749(84)90236-3.
       Full Text  Link to Item
    • Schwarz, H., H. J. Thiel, K. J. Weinhold, D. P. Bolognesi, and W. Schäfer. “Stimulation of Immunoreactivity against Endogenous Retroviruses and Protection against Leukemia of Older AKR Mice by Treatment with Antibodies against Retroviral Surface Components. Role of p 15(E) Antibody.” Zeitschrift Fur Naturforschung  Section C Journal of Biosciences 39, no. 11–12 (January 1, 1984): 1199–1202. https://doi.org/10.1515/znc-1984-11-1238.
       Full Text
    • Schwarz, H., H. J. Thiel, K. J. Weinhold, D. P. Bolognesi, and W. Schäfer. “[Stimulation of immunoreactivity against endogenous retroviruses and protection against leukemia in aged AKR mice after vaccination with antibodies to viral surface components. The role of antibodies to p15(E)].” Z Naturforsch C Biosci 39, no. 11–12 (1984): 1199–1202.
       Link to Item
    • Haynes, B. F., S. E. Miller, T. J. Palker, J. O. Moore, P. H. Dunn, D. P. Bolognesi, and R. S. Metzgar. “Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis.” Proc Natl Acad Sci U S A 80, no. 7 (April 1983): 2054–58. https://doi.org/10.1073/pnas.80.7.2054.
       Full Text  Link to Item
    • Watanabe, T., J. D. Iglehart, D. P. Bolognesi, E. B. Cox, A. Vaughn, and W. R. Hudson. “Elevated serum secretory immunoglobulin A levels in patients with head and neck carcinoma.” Otolaryngol Head Neck Surg 91, no. 2 (April 1983): 136–42. https://doi.org/10.1177/019459988309100205.
       Full Text  Link to Item
    • Iglehart, J. D., K. J. Weinhold, E. C. Ward, T. J. Matthews, A. J. Langlois, W. Schäfer, and D. P. Bolognesi. “Prospects for the immunological management of lethal tumors.” Cancer Invest 1, no. 5 (1983): 409–21. https://doi.org/10.3109/07357908309048509.
       Full Text  Link to Item
    • Watanabe, T., J. D. Iglehart, and D. P. Bolognesi. “Secretory immune response in patients with oropharyngeal carcinoma.” Ann Otol Rhinol Laryngol 92, no. 3 Pt 1 (1983): 295–99. https://doi.org/10.1177/000348948309200316.
       Full Text  Link to Item
    • Ward, E. C., J. D. Iglehart, K. J. Weinhold, and D. P. Bolognesi. “Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.” J Natl Cancer Inst 69, no. 2 (August 1982): 509–15.
       Link to Item
    • Fischinger, P. J., N. M. Dunlop, H. Schwarz, J. N. Ihle, K. Weinhold, D. P. Bolognesi, and W. Schafer. “XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells.” Virology 119, no. 1 (May 1982): 68–81. https://doi.org/10.1016/0042-6822(82)90066-6.
       Full Text  Link to Item
    • Matthews, T. J., E. M. Broughton, K. J. Weinhold, D. P. Bolognesi, T. Graf, and H. Beug. “Clonal isolate of the simian sarcoma virus codes for a Gag-related 65,000-dalton protein.” Virology 114, no. 1 (October 15, 1981): 124–31. https://doi.org/10.1016/0042-6822(81)90258-0.
       Full Text  Link to Item
    • Thiel, H. J., T. J. Matthews, E. M. Broughton, A. W. Butchko, and D. P. Bolognesi. “Detection of a transformation-specific glycopeptide in SSV-infected cells.” Virology 112, no. 2 (July 30, 1981): 642–50. https://doi.org/10.1016/0042-6822(81)90309-3.
       Full Text  Link to Item
    • Iglehart, J. D., M. J. Warzynski, R. C. Montelaro, D. P. Bolognesi, D. C. Sabiston, and W. G. Wolfe. “Function of the secretory immune system in bronchogenic carcinoma. Immunoglobulin A levels in respiratory secretions.” J Thorac Cardiovasc Surg 82, no. 1 (July 1981): 63–69.
       Link to Item
    • Iglehart, J. D., E. C. Ward, G. Huper, K. Thiel, and D. P. Bolognesi. “In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.” J Natl Cancer Inst 67, no. 1 (July 1981): 117–22.
       Link to Item
    • Iglehart, J. D., E. C. Ward, K. Thiel, G. Huper, S. S. Geier, and D. P. Bolognesi. “In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.” J Natl Cancer Inst 67, no. 1 (July 1981): 107–15.
       Link to Item
    • Iglehart, J. D., K. J. Weinhold, G. Huper, K. Thiel, and D. P. Bolognesi. “In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.” J Natl Cancer Inst 67, no. 1 (July 1981): 123–30.
       Link to Item
    • Langlois, A. J., T. Matthews, G. J. Roloson, H. J. Thiel, J. J. Collins, and D. P. Bolognesi. “Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.” J Immunol 126, no. 6 (June 1981): 2337–41.
       Link to Item
    • Matthews, T. J., J. J. Collins, G. J. Roloson, H. J. Thiel, and D. P. Bolognesi. “Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.” J Immunol 126, no. 6 (June 1981): 2332–36.
       Link to Item
    • Roloson, G. J., D. E. Haagensen, C. A. Chambers, and D. P. Bolognesi. “Immunologic control of the ascites form of murine adenocarcinoma 755. III. Efficacy of serum therapy is controlled by a single genetic locus.” J Immunol 126, no. 6 (June 1981): 2328–31.
       Link to Item
    • Schwarz, H., J. N. Ihle, E. Wecker, P. J. Fischinger, H. J. Thiel, D. P. Bolognesi, and W. Schäfer. “Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.” Virology 111, no. 2 (June 1981): 568–78. https://doi.org/10.1016/0042-6822(81)90358-5.
       Full Text  Link to Item
    • Thiel, H. J., E. M. Broughton, T. J. Matthews, W. Schäfer, and D. P. Bolognesi. “Interspecies reactivity of type C and D retrovirus p 15E and p 15C proteins.” Virology 111, no. 1 (May 1981): 270–74. https://doi.org/10.1016/0042-6822(81)90671-1.
       Full Text  Link to Item
    • Thiel, H. J., T. Matthews, E. Broughton, A. Butchko, and D. Bolognesi. “Characterization of antigens in SSV nonproducer cells.” Haematol Blood Transfus 26 (1981): 520–23. https://doi.org/10.1007/978-3-642-67984-1_96.
       Full Text  Link to Item
    • Cianciolo, G. J., T. J. Matthews, D. P. Bolognesi, and R. Snyderman. “Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.” J Immunol 124, no. 6 (June 1980): 2900–2905.
       Link to Item
    • Barbacid, M., D. Bolognesi, and S. A. Aaronson. “Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus.” Proc Natl Acad Sci U S A 77, no. 3 (March 1980): 1617–21. https://doi.org/10.1073/pnas.77.3.1617.
       Full Text  Link to Item
    • Montelaro, R. C., P. J. Fischinger, S. B. Larrick, N. M. Dunlop, J. N. Ihle, H. Frank, W. Schäfer, and D. P. Bolognesi. “Further characterization of the oncornavirus inactivating factor in normal mouse serum.” Virology 98, no. 1 (October 15, 1979): 20–34. https://doi.org/10.1016/0042-6822(79)90521-x.
       Full Text  Link to Item
    • Montelaro, R. C., and D. P. Bolognesi. “A procedure for the preferential radioiodination of small amounts of protein in the presence of excess lipids.” Anal Biochem 99, no. 1 (October 15, 1979): 92–96. https://doi.org/10.1016/0003-2697(79)90047-2.
       Full Text  Link to Item
    • Langlois, A. J., W. D. Holder, J. D. Iglehart, W. A. Nelson-Rees, S. A. Wells, and D. P. Bolognesi. “Morphological and biochemical properties of a new human breast cancer cell line.” Cancer Res 39, no. 7 Pt 1 (July 1979): 2604–13.
       Link to Item
    • Schwarz, H., P. J. Fischinger, J. N. Ihle, H. J. Thiel, F. Weiland, D. P. Bolognesi, and W. Schäfer. “Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71.” Virology 93, no. 1 (February 1979): 159–74. https://doi.org/10.1016/0042-6822(79)90284-8.
       Full Text  Link to Item
    • Iglehart, J. D., R. C. Montelaro, D. P. Bolognesi, D. C. Sabiston, and W. G. Wolfe. “Response of the secretory immune system to bronchogenic carcinoma of the lung.” Surg Forum 30 (1979): 118–19.
       Link to Item
    • Roloson, G. J., C. A. Chambers, D. E. Haagensen, R. C. Montelaro, and D. P. Bolognesi. “A single genetic locus determines the efficacy of serum therapy against murine adenocarcinoma 755a.” Haematol Blood Transfus 23 (1979): 469–81. https://doi.org/10.1007/978-3-642-67057-2_61.
       Full Text  Link to Item
    • Fischinger, P. J., A. E. Frankel, J. H. Elder, R. A. Lerner, J. N. Ihle, and D. P. Bolognesi. “Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus.” Virology 90, no. 2 (October 15, 1978): 241–54. https://doi.org/10.1016/0042-6822(78)90308-2.
       Full Text  Link to Item
    • Ihle, J. N., P. Fischinger, D. Bolognesi, J. Elder, and J. W. Gautsch. “B-MuX: a unique murine C-type virus containing the "env" gene of xenotropic viruses and the "gag" gene of the ecotropic virus.” Virology 90, no. 2 (October 15, 1978): 255–64. https://doi.org/10.1016/0042-6822(78)90309-4.
       Full Text  Link to Item
    • Collins, J. J., R. C. Montelaro, T. P. Denny, R. Ishizaki, A. J. Langlois, and D. P. Bolognest. “Normal chicken cells (chf-) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus.” Virology 86, no. 1 (May 1, 1978): 205–16. https://doi.org/10.1016/0042-6822(78)90021-1.
       Full Text  Link to Item
    • Noronha, F. de, W. Schäfer, M. Essex, and D. P. Bolognesi. “Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus.” Virology 85, no. 2 (April 1978): 617–21. https://doi.org/10.1016/0042-6822(78)90467-1.
       Full Text  Link to Item
    • Bolognesi, D. P., R. C. Montelaro, H. Frank, and W. Schäfer. “Assembly of type C oncornaviruses: a model.” Science 199, no. 4325 (January 13, 1978): 183–86. https://doi.org/10.1126/science.202022.
       Full Text  Link to Item
    • Ishizaki, R., R. W. Green, and D. P. Bolognesi. “The structural polypeptides of equine infections anemia virus.” Intervirology 9, no. 5 (1978): 286–94. https://doi.org/10.1159/000148946.
       Full Text  Link to Item
    • Montelaro, R. C., S. J. Sullivan, and D. P. Bolognesi. “An analysis of type-C retrovirus polypeptides and their associations in the virion.” Virology 84, no. 1 (January 1978): 19–31. https://doi.org/10.1016/0042-6822(78)90215-5.
       Full Text  Link to Item
    • Montelaro, R. C., and D. P. Bolognesi. “Structure and morphogenesis of type-C retroviruses.” Adv Cancer Res 28 (1978): 63–89. https://doi.org/10.1016/s0065-230x(08)60646-6.
       Full Text  Link to Item
    • Collins, J. J., G. Roloson, D. E. Haagensen, P. J. Fischinger, S. A. Wells, W. Holder, and D. P. Bolognesi. “Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.” J Natl Cancer Inst 60, no. 1 (January 1978): 141–52. https://doi.org/10.1093/jnci/60.1.141.
       Full Text  Link to Item
    • Haagensen, D. E., G. Roloson, J. J. Collins, S. A. Wells, D. P. Bolognesi, and H. J. Hansen. “Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.” J Natl Cancer Inst 60, no. 1 (January 1978): 131–39. https://doi.org/10.1093/jnci/60.1.131.
       Full Text  Link to Item
    • Schäfer, W., H. Schwarz, H. J. Thiel, P. J. Fischinger, and D. P. Bolognesi. “Properties of mouse leukemia viruses. XIV. Prevention of spontaneous AKR leukemia by treatment with group-specific antibody against the major virus gp71 glycoprotein.” Virology 83, no. 1 (November 1977): 207–10. https://doi.org/10.1016/0042-6822(77)90224-0.
       Full Text  Link to Item
    • Ghysdael, J., E. Hubert, M. Trávnícek, D. P. Bolognesi, A. Burny, Y. Cleuter, G. Huez, et al. “Frog oocytes synthesize and completely process the precursor polypeptide to virion structural proteins after microinjection of avian myeloblastosis virus RNA.” Proc Natl Acad Sci U S A 74, no. 8 (August 1977): 3230–34. https://doi.org/10.1073/pnas.74.8.3230.
       Full Text  Link to Item
    • Collins, J. J., L. D. Bolio, T. P. Denny, and D. P. Bolognesi. “Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay.” J Natl Cancer Inst 59, no. 1 (July 1977): 99–106. https://doi.org/10.1093/jnci/59.1.99.
       Full Text  Link to Item
    • Pitha, P. M., S. P. Staal, D. P. Bolognesi, T. P. Denny, and W. P. Rowe. “Effect of interferon on murine leukemia virus infection. II. Synthesis of viral components in exogenous infection.” Virology 79, no. 1 (June 1, 1977): 1–13. https://doi.org/10.1016/0042-6822(77)90329-4.
       Full Text  Link to Item
    • Kurth, R., V. Bosch, and D. P. Bolognesi. “Polypeptides of endogenous avian C-type viruses: their detection in the plasma membrane of normal and infected cells.” Virology 78, no. 2 (May 15, 1977): 511–21. https://doi.org/10.1016/0042-6822(77)90127-1.
       Full Text  Link to Item
    • Noronha, F. de, R. Baggs, W. Schäfer, and D. Bolognesi. “Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies.” Nature 267, no. 5606 (May 5, 1977): 54–56. https://doi.org/10.1038/267054a0.
       Full Text  Link to Item
    • Montelaro, R. C., A. C. Herman, and D. P. Bolognesi. “Transfer of radioiodine from iodinated oncornavirus proteins to unlabeled protein carrier during routine procedures for peptide mapping.” Biochem Biophys Res Commun 75, no. 1 (March 7, 1977): 38–44. https://doi.org/10.1016/0006-291x(77)91285-2.
       Full Text  Link to Item
    • Cloyd, M. W., D. P. Bolognesi, and D. D. Bigner. “Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.” Cancer Res 37, no. 3 (March 1977): 922–30.
       Link to Item
    • Cloyd, M. W., D. P. Bolognesi, and D. D. Bigner. “Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells.” Cancer Res 37, no. 3 (March 1977): 931–38.
       Link to Item
    • England, J. M., D. P. Bolognesi, B. Dietzschold, and M. S. Halpern. “Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus.” J Virol 21, no. 2 (February 1977): 810–14. https://doi.org/10.1128/JVI.21.2.810-814.1977.
       Full Text  Link to Item
    • Bolognesi, D. P., R. C. Montelaro, and S. J. Sullivan. “A model for assembly of type-c oncornaviruses.” Med Microbiol Immunol 164, no. 1–3 (1977): 97–113. https://doi.org/10.1007/BF02121306.
       Full Text  Link to Item
    • Collins, J. J., L. D. Bolio, T. P. Denny, and D. P. Bolognesi. “Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells.” J Virol 21, no. 1 (January 1977): 113–18. https://doi.org/10.1128/JVI.21.1.113-118.1977.
       Full Text  Link to Item
    • Fischinger, P. J., J. N. Ihle, F. de Noronha, and D. P. Bolognesi. “Oncogenic and immunogenic potential of cloned HIX virus in mice and cats.” Med Microbiol Immunol 164, no. 1–3 (1977): 119–29. https://doi.org/10.1007/BF02121308.
       Full Text  Link to Item
    • Ghysdael, J., E. Hubert, M. Travinicek, D. P. Bolognesi, Y. Cleuter, G. Huex, G. Marbaix, D. Portetelle, and H. Chantrenne. “Synthesis and complete processing of a high-molecular-weight precursor polypeptide to viral structural proteins in toad oocytes micro-injected with avian myeloblastosis virus ribonucleic acid [proceedings].” Biochem Soc Trans 5, no. 4 (1977): 950–53. https://doi.org/10.1042/bst0050950.
       Full Text  Link to Item
    • Schäfer, W., D. P. Bolognesi, F. de Noronha, P. J. Fischinger, G. Hunsmann, J. N. Ihle, V. Moenning, H. Schwarz, and H. J. Thiel. “Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats.” Med Microbiol Immunol 164, no. 1–3 (1977): 217–29. https://doi.org/10.1007/BF02121316.
       Full Text  Link to Item
    • Schäfer, W., P. J. Fischinger, J. J. Collins, and D. P. Bolognesi. “Role of carbohydrate in biological functions of Friend murine leukemia virus gp71.” J Virol 21, no. 1 (January 1977): 35–40. https://doi.org/10.1128/JVI.21.1.35-40.1977.
       Full Text  Link to Item
    • Schäfer, W., and D. P. Bolognesi. “Mammalian C-type oncornaviruses: relationships between viral structural and cell-surface antigens and their possible significance in immunological defense mechanisms.” Contemp Top Immunobiol 6 (1977): 127–67. https://doi.org/10.1007/978-1-4684-3051-6_4.
       Full Text  Link to Item
    • Holder, W. D., G. W. Peer, D. P. Bolognesi, and S. A. Wells. “Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.” Cancer Research 36, no. 9 (December 1, 1976).
    • Schäfer, W., H. Schwarz, H. J. Thiel, E. Wecker, and D. P. Bolognesi. “Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.” Virology 75, no. 2 (December 1976): 401–18. https://doi.org/10.1016/0042-6822(76)90039-8.
       Full Text  Link to Item
    • Ihle, J. N., J. C. Lee, J. J. Collins, P. J. Fischinger, N. H. Pazmino, V. Moennig, W. Schäfer, M. G. Hanna, and D. P. Bolognesi. “Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice.” Virology 75, no. 1 (November 1976): 88–101. https://doi.org/10.1016/0042-6822(76)90009-x.
       Full Text  Link to Item
    • Ihle, J. N., J. J. Collins, J. C. Lee, P. J. Fischinger, N. Pazmino, V. Moennig, W. Schäfer, M. G. Hanna, and D. P. Bolognesi. “Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.” Virology 75, no. 1 (November 1976): 102–12. https://doi.org/10.1016/0042-6822(76)90010-6.
       Full Text  Link to Item
    • Ihle, J. N., J. J. Collins, J. C. Lee, P. J. Fischinger, V. Moennig, W. Schäfer, M. G. Hanna, and D. P. Bolognesi. “Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.” Virology 75, no. 1 (November 1976): 74–87. https://doi.org/10.1016/0042-6822(76)90008-8.
       Full Text  Link to Item
    • Langlois, A. J., R. Ishizaki, G. S. Beaudreau, J. F. Kummer, J. W. Beard, and D. P. Bolognesi. “Virus-infected avian cell lines established in vitro.” Cancer Res 36, no. 11 Pt 1 (November 1976): 3894–3904.
       Link to Item
    • Holder, W. D., G. W. Peer, D. P. Bolognesi, and S. A. Wells. “Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.” Cancer Res 36, no. 9 pt.1 (September 1976): 3217–24.
       Link to Item
    • Fischinger, P. J., J. N. Ihle, D. P. Bolognesi, and W. Schäfer. “Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated.” Virology 71, no. 1 (May 1976): 346–51. https://doi.org/10.1016/0042-6822(76)90118-5.
       Full Text  Link to Item
    • Fischinger, P. J., W. Sch5AAFER, and D. P. Bolognesi. “Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus.” Virology 71, no. 1 (May 1976): 169–84. https://doi.org/10.1016/0042-6822(76)90103-3.
       Full Text  Link to Item
    • Halpern, M. S., D. P. Bolognesi, and R. R. Friis. “Viral glycoprotein synthesis studies in an established line of Japanese quail embryo cells infected with the Bryan high-titer strain of Rous sarcoma virus.” J Virol 18, no. 2 (May 1976): 504–10. https://doi.org/10.1128/JVI.18.2.504-510.1976.
       Full Text  Link to Item
    • Ihle, J. N., T. P. Denny, and D. P. Bolognesi. “Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice.” J Virol 17, no. 3 (March 1976): 727–36. https://doi.org/10.1128/JVI.17.3.727-736.1976.
       Full Text  Link to Item
    • Bolognesi, D. P. “Potential leukemia virus subunit vaccines: discussion.” Cancer Res 36, no. 2 pt 2 (February 1976): 655–56.
       Link to Item
    • Bolognesi, D. P., T. Rainey, and G. Hueper. “Structural components of RNA tumor viruses.” Oregon State Univ.Press, January 1, 1976, 35–59.
    • Cloyd, M. W., D. P. Bolognesi, P. J. Fischinger, and D. D. Bigner. “The antigenic expression of murine leukemia virus GP71 on murine and heterologous species cells.” Federation Proceedings 35, no. 3 (January 1, 1976).
    • Ghysdael, J., E. Hubert, M. Travnicek, D. P. Bolognesi, A. Burny, Y. Cleuter, M. Leclercq, et al. “Translation of 35S RNA from avian myeloblastosis virus into viral specific polypeptides in Xenopus oocytes.” Arch Int Physiol Biochim 84, no. 3 (1976): 619–21.
       Link to Item
    • Holder, W. D., G. W. Peer, D. P. Bolognesi, and S. A. Wells. “Antibody reacting with mouse mammary tumor virus in serum of breast carcinoma patients.” Surg Forum 27, no. 62 (1976): 102–4.
       Link to Item
    • Langlois, A. J., R. Ishizaki, J. F. Kummer, D. P. Bolognesi, G. S. Beaudreau, and J. W. Beard. “Virus-infected Avian Cell Lines Established in Vitro.” Cancer Research 36 (January 1, 1976): 3894–3904.
    • Metzgar, R. S., T. Mohanakumar, and D. P. Bolognesi. “Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.” J Exp Med 143, no. 1 (January 1, 1976): 47–63. https://doi.org/10.1084/jem.143.1.47.
       Full Text  Link to Item
    • Bolognesi, D. P., J. J. Collins, J. P. Leis, V. Moennig, W. Schäfer, and P. H. Atkinson. “Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus.” J Virol 16, no. 6 (December 1975): 1453–63. https://doi.org/10.1128/JVI.16.6.1453-1463.1975.
       Full Text  Link to Item
    • Fischinger, P. J., S. Nomura, and D. P. Bolognesi. “A novel murine oncornavirus with dual eco- and xenotropic properties.” Proc Natl Acad Sci U S A 72, no. 12 (December 1975): 5150–55. https://doi.org/10.1073/pnas.72.12.5150.
       Full Text  Link to Item
    • Bolognesi, D. P., A. J. Langlois, and W. Schäfer. “Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture.” Virology 68, no. 2 (December 1975): 550–55. https://doi.org/10.1016/0042-6822(75)90297-4.
       Full Text  Link to Item
    • Bolognesi, D. P. “Summary of session on oncornaviruses I. Virus-cell interactions and virus structure analyses.” Bibl Haematol, no. 43 (October 1975): 144–45.
       Link to Item
    • Fischinger, P. J., S. Nomura, C. S. Blevins, and D. P. Bolognesi. “Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus.” J Gen Virol 29, no. 1 (October 1975): 51–62. https://doi.org/10.1099/0022-1317-29-1-51.
       Full Text  Link to Item
    • Metzgar, R. S., T. Mohanakumar, and D. P. Bolognesi. “Antigenic relationships between murine, feline and primate RNA tumor viruses and membrane antigens of human leukemic cells.” Bibl Haematol, no. 43 (October 1975): 549–54. https://doi.org/10.1159/000399216.
       Full Text  Link to Item
    • Schäfer, W., M. Claviez, H. Frank, G. Hunsmann, V. Moennig, H. Schwarz, H. J. Thiel, et al. “Mammalian C-type oncorna viruses. Relationships between structural virus and cell surface antigens and their possible significance in immunological defense mechanisms.” Bibl Haematol, no. 43 (October 1975): 88–96.
       Link to Item
    • Rohrschneider, L., H. Bauer, and D. P. Bolognesi. “Group-specific antigenic determinants of the large envelope glycoprotein of avian oncornaviruses.” Virology 67, no. 1 (September 1975): 234–41. https://doi.org/10.1016/0042-6822(75)90420-1.
       Full Text  Link to Item
    • Lewandowski, L. J., R. E. Smith, D. P. Bolognesi, and M. S. Halpern. “Viral glycoprotein synthesis under conditions of glucosamine block in cells transformed by avian sarcoma viruses.” Virology 66, no. 2 (August 1975): 347–55. https://doi.org/10.1016/0042-6822(75)90208-1.
       Full Text  Link to Item
    • Fischinger, P. F., N. Tuttle-Fuller, G. Hüper, and D. P. Bolognesi. “Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection.” J Virol 16, no. 2 (August 1975): 267–74. https://doi.org/10.1128/JVI.16.2.267-274.1975.
       Full Text  Link to Item
    • Eiden, J. J., D. P. Bolognesi, A. J. Langlois, and J. L. Nichols. “The initial nucleotide sequence of DNA transcribed from avian myeloblastosis virus 70 S RNA by RNA-dependent DNA polymerase.” Virology 65, no. 1 (May 1975): 163–72. https://doi.org/10.1016/0042-6822(75)90016-1.
       Full Text  Link to Item
    • Halpern, M. S., D. P. Bolognesi, R. R. Friis, and W. S. Mason. “Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos.” J Virol 15, no. 5 (May 1975): 1131–40. https://doi.org/10.1128/JVI.15.5.1131-1140.1975.
       Full Text  Link to Item
    • Bolognesi, D. P., R. Ishizaki, G. Hüper, T. C. Vanaman, and R. E. Smith. “Immunological properties of avian oncornavirus polypeptides.” Virology 64, no. 2 (April 1975): 349–57. https://doi.org/10.1016/0042-6822(75)90111-7.
       Full Text  Link to Item
    • Herman, A. C., R. W. Green, D. P. Bolognesi, and T. C. Vanaman. “Comparative chemical properties of avian oncornavirus polypeptides.” Virology 64, no. 2 (April 1975): 339–48. https://doi.org/10.1016/0042-6822(75)90110-5.
       Full Text  Link to Item
    • Ishizaki, R., A. J. Langlois, and D. P. Bolognesi. “Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus.” J Virol 15, no. 4 (April 1975): 906–12. https://doi.org/10.1128/JVI.15.4.906-912.1975.
       Full Text  Link to Item
    • Grant, J. P., M. S. Curtas, D. P. Bolognesi, and S. A. Wells. “Cross-reactions of virally and chemically induced mouse sarcomas: surface expression of a common viral antigen.” Surg Forum 26 (1975): 177–79.
       Link to Item
    • Ihle, J. N., M. G. Hanna, W. Schafer, G. Hunsmann, D. P. Bolognesi, and G. HUPER. “Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody.” Virology 63, no. 1 (January 1975): 60–67. https://doi.org/10.1016/0042-6822(75)90370-0.
       Full Text  Link to Item
    • Ishizaki, R., and D. P. Bolognesi. “Reactivity of avian RNA tumor viruses with lectins.” J Virol 17, no. 1 (January 1975): 132–39. https://doi.org/10.1128/JVI.17.1.132-139.1976.
       Full Text  Link to Item
    • Schafer, W., G. Hunsmann, V. Moennig, F. Noranha, D. P. Bolognesi, R. W. Green, and G. Hüper. “Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity.” Virology 63, no. 1 (January 1975): 48–59. https://doi.org/10.1016/0042-6822(75)90369-4.
       Full Text  Link to Item
    • Schäfer, W., A. Demsey, H. Frank, G. Hunsmann, J. Lange, V. Moennig, L. Pister, et al. “Morphological, chemical, and antigenic organization of mammalian C-type viruses.” Bibl Haematol, no. 40 (1975): 497–515. https://doi.org/10.1159/000397568.
       Full Text  Link to Item
    • Schäfer, W., G. Hunsmann, V. Moennig, F. de Noronha, D. P. Bolognesi, R. W. Green, and G. Hüper. “Polypeptides of mammalian oncornaviruses. II. Characterization of a murine leukemia virus polypeptide (p15) bearing interspecies reactivity.” Virology 63, no. 1 (January 1975): 48–59.
       Link to Item
    • Bolognesi, D. P., G. Huper, R. W. Green, and T. Graf. “Biochemical properties of oncornavirus polypeptides.” Biochim Biophys Acta 355, no. 3–4 (December 31, 1974): 220–35. https://doi.org/10.1016/0304-419x(74)90011-0.
       Full Text  Link to Item
    • Grant, J. P., D. D. Bigner, P. J. Fischinger, and D. P. Bolognesi. “Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas.” Proc Natl Acad Sci U S A 71, no. 12 (December 1974): 5037–41. https://doi.org/10.1073/pnas.71.12.5037.
       Full Text  Link to Item
    • Luftig, R. B., P. N. McMillan, and D. P. Bolognesi. “An ultrastructural study of C-type virion assembly in mouse cells.” Cancer Res 34, no. 12 (December 1974): 3303–10.
       Link to Item
    • August, J. T., D. P. Bolognesi, E. Fleissner, R. V. Gilden, and R. C. Nowinski. “A proposed nomenclature for the virion proteins of oncogenic RNA viruses.” Virology 60, no. 2 (August 1974): 595–600. https://doi.org/10.1016/0042-6822(74)90356-0.
       Full Text  Link to Item
    • Luftig, R. B., P. N. McMillan, K. Culbreth, and D. P. Bolognesi. “A determination of the outer dimensions of oncornaviruses by several electron microscopic procedures.” Cancer Res 34, no. 7 (July 1974): 1694–1706.
       Link to Item
    • Halpern, M. S., D. P. Bolognesi, and L. J. Lewandowski. “Isolation of the major viral glycoprotein and a putative precursor from cells transformed by avian sarcoma viruses.” Proc Natl Acad Sci U S A 71, no. 6 (June 1974): 2342–46. https://doi.org/10.1073/pnas.71.6.2342.
       Full Text  Link to Item
    • Langlois, A. J., K. Lapis, R. Ishizaki, J. W. Beard, and D. P. Bolognesi. “Isolation of a transplantable cell line induced by the MC29 avian leukosis virus.” Cancer Res 34, no. 6 (June 1974): 1457–64.
       Link to Item
    • Metzgar, R. S., T. Mohanakumar, R. W. Green, D. S. Miller, and D. P. Bolognesi. “Human leukemia antigens: partial isolation and characterization.” J Natl Cancer Inst 52, no. 5 (May 1974): 1445–53. https://doi.org/10.1093/jnci/52.5.1445.
       Full Text  Link to Item
    • Bolognesi, D. P. “Structural components of rna tumor viruses.” Adv Virus Res 19 (1974): 315–59. https://doi.org/10.1016/s0065-3527(08)60663-6.
       Full Text  Link to Item
    • Green, R. W., and D. P. Bolognesi. “Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses.” Anal Biochem 57, no. 1 (January 1974): 108–17. https://doi.org/10.1016/0003-2697(74)90057-8.
       Full Text  Link to Item
    • Dalton, A. J., J. L. Melnick, H. Bauer, G. Beaudreau, P. Bentvelzen, D. Bolognesi, R. Gallo, et al. “The case for a family of reverse transcriptase viruses: Retraviridae.” Intervirology 4, no. 4 (1974): 201–6. https://doi.org/10.1159/000149963.
       Full Text  Link to Item
    • Bolognesi, D. P., R. Luftig, and J. H. Shaper. “Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.” Virology 56, no. 2 (December 1973): 549–64. https://doi.org/10.1016/0042-6822(73)90057-3.
       Full Text  Link to Item
    • Green, R. W., D. P. Bolognesi, W. Schäfer, L. Pister, G. Hunsmann, and F. De Noronha. “Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses.” Virology 56, no. 2 (December 1973): 565–79. https://doi.org/10.1016/0042-6822(73)90058-5.
       Full Text  Link to Item
    • Ishizaki, R., R. B. Luftig, and D. P. Bolognesi. “Outer membrane of avian myeloblastosis virus.” J Virol 12, no. 6 (December 1973): 1579–88. https://doi.org/10.1128/JVI.12.6.1579-1588.1973.
       Full Text  Link to Item
    • Bolognesi, D. P., H. Bauer, H. Gelderblom, and K. Mölling. “Structural components of avian myeloblastosis virus.” Bibl Haematol 39 (1973): 316–30. https://doi.org/10.1159/000427858.
       Full Text  Link to Item
    • Mölling, K., D. P. Bolognesi, H. Bauer, W. Büsen, H. W. Plassmann, and P. Hausen. “Association of the viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids.” Bibl Haematol 39 (1973): 536–50. https://doi.org/10.1159/000427884.
       Full Text  Link to Item
    • Bauer, H., D. P. Bolognesi, H. Gelderblom, T. Graf, R. Kurth, and K. Mölling. “[Chicken RNA tumor viruses: a model for virus-induced carcinogenesis].” Zentralbl Bakteriol Orig A 220, no. 1 (May 1972): 66–78.
       Link to Item
    • Gelderblom, H., H. Bauer, D. P. Bolognesi, and H. Frank. “[Morphogenesis and structure of RNA tumor viruses. Electron microscopy studies on C-type viruses].” Zentralbl Bakteriol Orig A 220, no. 1 (May 1972): 79–90.
       Link to Item
    • Bolognesi, D. P., H. Bauer, H. Gelderblom, and G. Hüper. “Polypeptides of avian RNA tumor viruses. IV. Components of the viral envelope.” Virology 47, no. 3 (March 1972): 551–66. https://doi.org/10.1016/0042-6822(72)90545-4.
       Full Text  Link to Item
    • Bolognesi, D. P., H. Gelderblom, H. Bauer, K. Mölling, and G. Hüper. “Polypeptides of avian RNA tumor viruses. V. Analysis of the virus core.” Virology 47, no. 3 (March 1972): 567–78. https://doi.org/10.1016/0042-6822(72)90546-6.
       Full Text  Link to Item
    • Schäfer, W., J. Lange, P. J. Fischinger, H. Frank, D. P. Bolognesi, and L. Pister. “Properties of mouse leukemia viruses. II. Isolation of viral components.” Virology 47, no. 1 (January 1972): 210–28. https://doi.org/10.1016/0042-6822(72)90253-x.
       Full Text  Link to Item
    • Mölling, K., D. P. Bolognesi, H. Bauer, W. Büsen, H. W. Plassmann, and P. Hausen. “Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids.” Nat New Biol 234, no. 51 (December 22, 1971): 240–43. https://doi.org/10.1038/newbio234240a0.
       Full Text  Link to Item
    • Moelling, K., D. P. Bolognesi, and H. Bauer. “Polypeptides of avian RNA tumor viruses. 3. Purification and identification of a DNA synthesizing enzyme.” Virology 45, no. 1 (July 1971): 298–302. https://doi.org/10.1016/0042-6822(71)90137-1.
       Full Text  Link to Item
    • Obara, T., D. P. Bolognesi, and H. Bauer. “Ribosomal RNA in avian leukosis virus particles.” Int J Cancer 7, no. 3 (May 15, 1971): 535–46. https://doi.org/10.1002/ijc.2910070320.
       Full Text  Link to Item
    • Schäfer, W., J. Lange, D. P. Bolognesi, F. De Noronha, J. E. Post, and C. G. Rickard. “Isolation and characterization of two group-specific antigens from feline leukemia virus.” Virology 44, no. 1 (April 1971): 73–82. https://doi.org/10.1016/0042-6822(71)90154-1.
       Full Text  Link to Item
    • Graf, T., H. Bauer, H. Gelderblom, and D. P. Bolognesi. “Studies on the reproductive and cell-converting abilities of avian sarcoma viruses.” Virology 43, no. 2 (February 1971): 427–41. https://doi.org/10.1016/0042-6822(71)90315-1.
       Full Text  Link to Item
    • Bolognesi, D. P., and T. Graf. “Size differences among the high molecular weight RNA's of avian tumor viruses.” Virology 43, no. 1 (January 1971): 214–22. https://doi.org/10.1016/0042-6822(71)90239-x.
       Full Text  Link to Item
    • Bauer, H., and D. P. Bolognesi. “Polypeptides of avian RNA tumor viruses. II. Serological characterization.” Virology 42, no. 4 (December 1970): 1113–26. https://doi.org/10.1016/0042-6822(70)90358-2.
       Full Text  Link to Item
    • Bolognesi, D. P., and H. Bauer. “Polypeptides of avian RNA tumor viruses. 1. Isolation and physical and chemical analysis.” Virology 42, no. 4 (December 1970): 1097–1112. https://doi.org/10.1016/0042-6822(70)90357-0.
       Full Text  Link to Item
    • Bauer, H., H. Tozawa, D. P. Bolognesi, T. Graf, and H. Gelderblom. “Structure and specific antigens of avian leukosis viruses.” Bibl Haematol, no. 36 (1970): 113–25. https://doi.org/10.1159/000391699.
       Full Text  Link to Item
    • Bolognesi, D. P., and T. Obara. “Minor RNA and other components of host origin intrinsic to avian leukosis virus particles.” Bibl Haematol, no. 36 (1970): 126–39. https://doi.org/10.1159/000391700.
       Full Text  Link to Item
    • Langlois, A. J., R. B. Fritz, U. Heine, D. Beard, D. P. Bolognesi, and J. W. Beard. “Response of bone marrow to MC29 avian leukosis virus in vitro.” Cancer Res 29, no. 11 (November 1969): 2056–74.
       Link to Item
    • Langlois, A. J., D. P. Bolognesi, R. B. Fritz, and J. W. Beard. “Strain MC29 avian leukosis virus release by chick embryo cells infected with the agent.” Proc Soc Exp Biol Med 131, no. 1 (May 1969): 138–43. https://doi.org/10.3181/00379727-131-33823.
       Full Text  Link to Item
    • Bolognesi, D. P., A. J. Langlois, L. Sverak, R. A. Bonar, and J. W. Beard. “In vitro chick embryo cell response to strain MC29 avian leukosis virus.” J Virol 2, no. 6 (June 1968): 576–86. https://doi.org/10.1128/JVI.2.6.576-586.1968.
       Full Text  Link to Item
    • Bonar, R. A., L. Sverak, D. P. Bolognesi, A. J. Langlois, D. Beard, and J. W. Beard. “Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus.” Cancer Res 27, no. 6 (June 1967): 1138–57.
       Link to Item
    • Langlois, A. J., R. A. Bonar, D. P. Bolognesi, D. Beard, J. W. Beard, and P. R. Rao. “BAI strain A avian (myeloblastosis) leukosis virus from myeloblast tissue culture.” Proc Soc Exp Biol Med 123, no. 1 (October 1966): 286–90. https://doi.org/10.3181/00379727-123-31468.
       Full Text  Link to Item
    • Bolognesi, D. P., and D. E. Wilson. “Inhibitory proteins in the Newcastle disease virus-induced suppression of cell protein synthesis.” J Bacteriol 91, no. 5 (May 1966): 1896–1901. https://doi.org/10.1128/jb.91.5.1896-1901.1966.
       Full Text  Link to Item

  • Book Sections

    • Gallo, R. C., P. J. Fischinger, and D. P. Bolognesi. “Vaccine strategies against the human retroviruses associated with AIDS.” In Vaccine Intervention Against Virus-Induced Tumour: Leukaemia and Lymphoma Research, 81–91, 2016. https://doi.org/10.1007/978-1-349-08243-8.
       Full Text
    • Putnam, R. D., and K. A. Goss. “Introduction.” In Democracies in Flux: The Evolution of Social Capital in Contemporary Society. New York: Oxford University Press, 2002.

  • Other Articles

    • Sabbaj, S., M. J. Mulligan, R. H. Hsieh, R. B. Belshe, and J. R. McGhee. “Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group.” Aids, July 7, 2000. https://doi.org/10.1097/00002030-200007070-00009.
       Full Text  Link to Item
    • Gorse, G. J., L. Corey, G. B. Patel, M. Mandava, R. H. Hsieh, T. J. Matthews, M. C. Walker, et al. “HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.” Aids Res Hum Retroviruses, January 20, 1999. https://doi.org/10.1089/088922299311547.
       Full Text  Link to Item
    • Gorse, G. J., M. J. McElrath, T. J. Matthews, R. H. Hsieh, R. B. Belshe, L. Corey, S. E. Frey, D. J. Kennedy, M. C. Walker, and M. M. Eibl. “Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.” Vaccine, March 1998. https://doi.org/10.1016/s0264-410x(97)80003-5.
       Full Text  Link to Item
    • LaRosa, G. J., K. Weinhold, A. T. Profy, A. J. Langlois, G. R. Dreesman, R. N. Boswell, P. Shadduck, D. P. Bolognesi, T. J. Matthews, and E. A. Emini. “Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications.” Science, September 6, 1991. https://doi.org/10.1126/science.1887238.
       Full Text  Link to Item
    • LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, and P. Shadduck. “Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications.” Science, February 15, 1991. https://doi.org/10.1126/science.1990444.
       Full Text  Link to Item
    • Matthews, T. J., H. Kim Lyerly, K. J. Weinhold, A. J. Langlois, S. D. Putney, and D. P. Bolognesi. “Prospects for development of a vaccine against HIV-related disorders.” Clinical Immunology Newsletter, January 1, 1987. https://doi.org/10.1016/0197-1859(87)90033-1.
       Full Text

  • Conference Papers

    • Desjardins, Annick, Matthias Gromeier, James Emmett Herndon, Dina Randazzo, Stevie Threatt, Eric S. Lipp, Elizabeth S. Miller, et al. “Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.” In Journal of Clinical Oncology, 37:101s-101s. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/JCO.2019.37.15_suppl.2060.
       Full Text  Link to Item
    • Bolognesi, D. P. “HIV: Vaccine and treatment strategies.” In Archives of Aids Research, 4:314–15, 1990.
    • Tyler, D. S., S. D. Stanley, E. A. Bumpas, J. A. Bartlett, D. P. Bolognesi, and K. J. Weinhold. “The antiretroviral effects of lymphokine-activated killer cells.” In Surgical Forum, 40:435–37, 1989.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.